Latest Breaking News On - Roanna ruiz - Page 1 : vimarsana.com

Stocks poised to move as this corner of the cancer therapy market heats up

Radiopharmaceuticals seek to destroy cancer cells by binding a radioactive particle to a targeted molecule and then dispatching it directly into the tumor.

scPharmaceuticals Inc. (NASDAQ:SCPH) Q1 2024 Earnings Call Transcript

Cytokinetics Stock: How Its New Drug Could Be A Safer Version Of Bristol's Camzyos

Cytokinetics Stock: How Its New Drug Could Be A Safer Version Of Bristol's Camzyos

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q1 2024 Earnings Call Transcript

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q1 2024 Earnings Call Transcript

Operator: Good day, everyone, and welcome to the Lexicon Pharmaceuticals First Quarter 2024 Financial Results Conference Call. At this time all participants are in a listen-only mode.

Ardelyx, Inc. (NASDAQ:ARDX) Q1 2024 Earnings Call Transcript

Ardelyx, Inc. beats earnings expectations. Reported EPS is $-0.11, expectations were $-0.13. Ardelyx, Inc.

Amarin Corporation plc (NASDAQ:AMRN) Q1 2024 Earnings Call Transcript

Amarin Corporation plc (NASDAQ:AMRN) Q1 2024 Earnings Call Transcript May 1, 2024 Amarin Corporation plc misses on earnings expectations. Reported EPS is $-0.01 EPS, expectations were $-0.0075. AMRN isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and welcome […]

Lantheus Holdings, Inc. (NASDAQ:LNTH) Q1 2024 Earnings Call Transcript

Lantheus Holdings, Inc. beats earnings expectations. Reported EPS is $1.69, expectations were $1.55. Lantheus Holdings, Inc.

United Therapeutics Corporation (NASDAQ:UTHR) Q1 2024 Earnings Call Transcript

United Therapeutics Corporation beats earnings expectations. Reported EPS is $6.17, expectations were $5.65.